<?xml version="1.0" encoding="UTF-8"?>
<RUN_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <RUN accession="ERR1518932" alias="E-MTAB-4851:NG-7454_Astex_CR1_lib46153_2692_1_" broker_name="ArrayExpress" center_name="Astex Pharmaceuticals" run_center="GATC Biotech">
    <IDENTIFIERS>
      <PRIMARY_ID>ERR1518932</PRIMARY_ID>
      <SUBMITTER_ID namespace="Astex Pharmaceuticals">E-MTAB-4851:NG-7454_Astex_CR1_lib46153_2692_1_</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2500 paired end sequencing; Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib</TITLE>
    <EXPERIMENT_REF accession="ERX1589911">
      <IDENTIFIERS>
        <PRIMARY_ID>ERX1589911</PRIMARY_ID>
      </IDENTIFIERS>
    </EXPERIMENT_REF>
    <SPOT_DESCRIPTOR>
      <SPOT_DECODE_SPEC>
        <SPOT_LENGTH>202</SPOT_LENGTH>
        <READ_SPEC>
          <READ_INDEX>0</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Forward</READ_TYPE>
          <BASE_COORD>1</BASE_COORD>
        </READ_SPEC>
        <READ_SPEC>
          <READ_INDEX>1</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Reverse</READ_TYPE>
          <BASE_COORD>102</BASE_COORD>
        </READ_SPEC>
      </SPOT_DECODE_SPEC>
    </SPOT_DESCRIPTOR>
    <RUN_ATTRIBUTES>
      <RUN_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2016-09-05</VALUE>
      </RUN_ATTRIBUTE>
      <RUN_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2018-11-16</VALUE>
      </RUN_ATTRIBUTE>
    </RUN_ATTRIBUTES>
  </RUN>
  <RUN accession="ERR1518933" alias="E-MTAB-4851:NG-7454_Astex_CR2_lib46154_2631_7_" broker_name="ArrayExpress" center_name="Astex Pharmaceuticals" run_center="GATC Biotech">
    <IDENTIFIERS>
      <PRIMARY_ID>ERR1518933</PRIMARY_ID>
      <SUBMITTER_ID namespace="Astex Pharmaceuticals">E-MTAB-4851:NG-7454_Astex_CR2_lib46154_2631_7_</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2500 paired end sequencing; Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib</TITLE>
    <EXPERIMENT_REF accession="ERX1589912">
      <IDENTIFIERS>
        <PRIMARY_ID>ERX1589912</PRIMARY_ID>
      </IDENTIFIERS>
    </EXPERIMENT_REF>
    <SPOT_DESCRIPTOR>
      <SPOT_DECODE_SPEC>
        <SPOT_LENGTH>202</SPOT_LENGTH>
        <READ_SPEC>
          <READ_INDEX>0</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Forward</READ_TYPE>
          <BASE_COORD>1</BASE_COORD>
        </READ_SPEC>
        <READ_SPEC>
          <READ_INDEX>1</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Reverse</READ_TYPE>
          <BASE_COORD>102</BASE_COORD>
        </READ_SPEC>
      </SPOT_DECODE_SPEC>
    </SPOT_DESCRIPTOR>
    <RUN_ATTRIBUTES>
      <RUN_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2016-09-05</VALUE>
      </RUN_ATTRIBUTE>
      <RUN_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2018-11-16</VALUE>
      </RUN_ATTRIBUTE>
    </RUN_ATTRIBUTES>
  </RUN>
  <RUN accession="ERR1518934" alias="E-MTAB-4851:NG-7454_Astex_CR4_lib46155_2631_7_" broker_name="ArrayExpress" center_name="Astex Pharmaceuticals" run_center="GATC Biotech">
    <IDENTIFIERS>
      <PRIMARY_ID>ERR1518934</PRIMARY_ID>
      <SUBMITTER_ID namespace="Astex Pharmaceuticals">E-MTAB-4851:NG-7454_Astex_CR4_lib46155_2631_7_</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2500 paired end sequencing; Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib</TITLE>
    <EXPERIMENT_REF accession="ERX1589913">
      <IDENTIFIERS>
        <PRIMARY_ID>ERX1589913</PRIMARY_ID>
      </IDENTIFIERS>
    </EXPERIMENT_REF>
    <SPOT_DESCRIPTOR>
      <SPOT_DECODE_SPEC>
        <SPOT_LENGTH>202</SPOT_LENGTH>
        <READ_SPEC>
          <READ_INDEX>0</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Forward</READ_TYPE>
          <BASE_COORD>1</BASE_COORD>
        </READ_SPEC>
        <READ_SPEC>
          <READ_INDEX>1</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Reverse</READ_TYPE>
          <BASE_COORD>102</BASE_COORD>
        </READ_SPEC>
      </SPOT_DECODE_SPEC>
    </SPOT_DESCRIPTOR>
    <RUN_ATTRIBUTES>
      <RUN_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2016-09-05</VALUE>
      </RUN_ATTRIBUTE>
      <RUN_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2018-11-16</VALUE>
      </RUN_ATTRIBUTE>
    </RUN_ATTRIBUTES>
  </RUN>
  <RUN accession="ERR1518935" alias="E-MTAB-4851:NG-7454_Astex_CR5_lib46156_2631_6_" broker_name="ArrayExpress" center_name="Astex Pharmaceuticals" run_center="GATC Biotech">
    <IDENTIFIERS>
      <PRIMARY_ID>ERR1518935</PRIMARY_ID>
      <SUBMITTER_ID namespace="Astex Pharmaceuticals">E-MTAB-4851:NG-7454_Astex_CR5_lib46156_2631_6_</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2500 paired end sequencing; Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib</TITLE>
    <EXPERIMENT_REF accession="ERX1589914">
      <IDENTIFIERS>
        <PRIMARY_ID>ERX1589914</PRIMARY_ID>
      </IDENTIFIERS>
    </EXPERIMENT_REF>
    <RUN_ATTRIBUTES>
      <RUN_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2016-09-05</VALUE>
      </RUN_ATTRIBUTE>
      <RUN_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2018-11-16</VALUE>
      </RUN_ATTRIBUTE>
    </RUN_ATTRIBUTES>
  </RUN>
  <RUN accession="ERR1518936" alias="E-MTAB-4851:NG-7454_Astex_CR6_6_lib46157_2631_6_" broker_name="ArrayExpress" center_name="Astex Pharmaceuticals" run_center="GATC Biotech">
    <IDENTIFIERS>
      <PRIMARY_ID>ERR1518936</PRIMARY_ID>
      <SUBMITTER_ID namespace="Astex Pharmaceuticals">E-MTAB-4851:NG-7454_Astex_CR6_6_lib46157_2631_6_</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2500 paired end sequencing; Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib</TITLE>
    <EXPERIMENT_REF accession="ERX1589915">
      <IDENTIFIERS>
        <PRIMARY_ID>ERX1589915</PRIMARY_ID>
      </IDENTIFIERS>
    </EXPERIMENT_REF>
    <RUN_ATTRIBUTES>
      <RUN_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2016-09-05</VALUE>
      </RUN_ATTRIBUTE>
      <RUN_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2018-11-16</VALUE>
      </RUN_ATTRIBUTE>
    </RUN_ATTRIBUTES>
  </RUN>
  <RUN accession="ERR1518937" alias="E-MTAB-4851:NG-7454_Astex_CR7_lib46158_2631_2_" broker_name="ArrayExpress" center_name="Astex Pharmaceuticals" run_center="GATC Biotech">
    <IDENTIFIERS>
      <PRIMARY_ID>ERR1518937</PRIMARY_ID>
      <SUBMITTER_ID namespace="Astex Pharmaceuticals">E-MTAB-4851:NG-7454_Astex_CR7_lib46158_2631_2_</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2500 paired end sequencing; Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib</TITLE>
    <EXPERIMENT_REF accession="ERX1589916">
      <IDENTIFIERS>
        <PRIMARY_ID>ERX1589916</PRIMARY_ID>
      </IDENTIFIERS>
    </EXPERIMENT_REF>
    <SPOT_DESCRIPTOR>
      <SPOT_DECODE_SPEC>
        <SPOT_LENGTH>202</SPOT_LENGTH>
        <READ_SPEC>
          <READ_INDEX>0</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Forward</READ_TYPE>
          <BASE_COORD>1</BASE_COORD>
        </READ_SPEC>
        <READ_SPEC>
          <READ_INDEX>1</READ_INDEX>
          <READ_CLASS>Application Read</READ_CLASS>
          <READ_TYPE>Reverse</READ_TYPE>
          <BASE_COORD>102</BASE_COORD>
        </READ_SPEC>
      </SPOT_DECODE_SPEC>
    </SPOT_DESCRIPTOR>
    <RUN_ATTRIBUTES>
      <RUN_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2016-09-05</VALUE>
      </RUN_ATTRIBUTE>
      <RUN_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2018-11-16</VALUE>
      </RUN_ATTRIBUTE>
    </RUN_ATTRIBUTES>
  </RUN>
  <RUN accession="ERR1518938" alias="E-MTAB-4851:NG-7454_Astex_CS_lib46152_2631_2_" broker_name="ArrayExpress" center_name="Astex Pharmaceuticals" run_center="GATC Biotech">
    <IDENTIFIERS>
      <PRIMARY_ID>ERR1518938</PRIMARY_ID>
      <SUBMITTER_ID namespace="Astex Pharmaceuticals">E-MTAB-4851:NG-7454_Astex_CS_lib46152_2631_2_</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2500 paired end sequencing; Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib</TITLE>
    <EXPERIMENT_REF accession="ERX1589917">
      <IDENTIFIERS>
        <PRIMARY_ID>ERX1589917</PRIMARY_ID>
      </IDENTIFIERS>
    </EXPERIMENT_REF>
    <RUN_ATTRIBUTES>
      <RUN_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2016-09-05</VALUE>
      </RUN_ATTRIBUTE>
      <RUN_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2018-11-16</VALUE>
      </RUN_ATTRIBUTE>
    </RUN_ATTRIBUTES>
  </RUN>
</RUN_SET>
